ECRI Newsroom
Read the latest news about ECRI’s independent research and initiatives to advance effective, evidence-based healthcare globally.
Misuse of AI chatbots tops annual list of health technology hazards
Chatbots that rely on large language models (LLMs) — such as ChatGPT, Claude, Copilot, Gemini, and Grok — produce human-like and expert-sounding responses to users’ questions. The tools are not regulated as medical devices nor validated for healthcare purposes but are increasingly used by clinicians, patients, and healthcare personnel. More than 40 million people daily turn to ChatGPT for health information, according to a recent analysis from OpenAI.
Op-Ed: "Cultural Transformation Can Fix The Broken Hospital Safety Reporting System"
ISMP Awarded FDA Contract to Support Medication Error Prevention
Protecting Patients Strengthens the Bottom Line
Creating a Culture of Safety in Healthcare: What It Really Takes
Patient Safety Practices to Prevent Nonventilator Hospital-Acquired Pneumonia
Stay In the Know
Sign up to have ECRI news, insights, and resources delivered directly to your inbox.
ECRI
Media Inquiries
For media inquiries and interviews with ECRI’s subject matter experts, please contact Yvonne Rhodes, Associate Director of Strategic Communications, at yrhodes@ecri.org.
View The Latest from ISMP
News Release
Preventing Wrong Drug-Wrong Route Errors Involving Tranexamic Acid and Local Anesthetics
Joint Announcement from the Anesthesia Patient Safety Foundation (APSF) and the Institute for Safe Medication Practices (ISMP) Medication administration errors remain one of the most common and ser...
En savoir plusNews Release
ISMP Announces 28th Annual Cheers Award Recipients
Awardees Focused on Smart Pump Integration, Safe Chemotherapy Handling, and Patient Partnership The Institute for Safe Medication Practices (ISMP) is proud to announce the 28th Annual Cheers Award ...
En savoir plusNews Release
ISMP Awarded FDA Contract to Support Medication Error Prevention
The Institute for Safe Medication Practices (ISMP), an ECRI company, has been awarded a contract from the U.S. Food and Drug Administration (FDA) to provide expert analysis and data-driven insights...
En savoir plusISMP
Media Inquiries
For media inquiries and interviews with ISMP's subject matter experts, please contact Renee Brehio at rbrehio@ismp.org.